Pivotal Assessment of the Effects of Bioactive on Health and Wellbeing. From Human Genome to Food Industry (PATHWAY-27)
Investigation of the Effect of Daily Consumption of Bioactive Enriched Foods (BEF) on Biochemical and Anthropometric Markers of Metabolic Syndrome (MS)
Sponsor: Centre de Recherche en Nutrition Humaine d'Auvergne
Terminated
The funding agency set a mandatory deadline for the study in order to be able to conclude the project.
A NA clinical study on Metabolic Syndrome, this trial is terminated or withdrawn. The trial is conducted by Centre de Recherche en Nutrition Humaine d'Auvergne and has accumulated 10 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
-
Oct 2021 — Dec 2021 [monthly]
Terminated NA
-
Jan 2021 — Oct 2021 [monthly]
Terminated NA
▶ Show 5 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated NA
-
Jun 2018 — Nov 2020 [monthly]
Terminated NA
-
May 2018 — Jun 2018 [monthly]
Terminated NA
-
Dec 2017 — May 2018 [monthly]
Terminated NA
Status: Recruiting → Terminated · Phase: PHASE2 → NA
-
Jan 2017 — Dec 2017 [monthly]
Recruiting PHASE2
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre de Recherche en Nutrition Humaine d'Auvergne
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Max Rubner-Institut
- University of Bologna
- University of Leeds
For direct contact, visit the study record on ClinicalTrials.gov .